Waheed Jamal

13.6k citations

21 papers · 2.4k indexed · 3 hit papers · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Cardiology and Cardiovascular Medicine top 1%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 17
- Diabetes Treatment and Management 17
- Diabetes Management and Research 2
Cardiology and Cardiovascular Medicine 12
- Heart Failure Treatment and Management 9
- Cardiovascular Function and Risk Factors 3
- Atrial Fibrillation Management and Outcomes 2

Co-authors: Martina Brueckmann (14 shared papers)Gerasimos Filippatos (12 shared papers)Faı̈ez Zannad (13 shared papers)Milton Packer (13 shared papers)Javed Butler (10 shared papers)Stefan D. Anker (14 shared papers)Stuart Pocock (13 shared papers)João Pedro Ferreira (10 shared papers)
Journals: European Journal of Heart Failure (4 papers)European Heart Journal (3 papers)Journal of the American College of Cardiology (3 papers)Circulation (2 papers)Human Gene Therapy (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Waheed Jamal

17 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction 2020 · 266 citations

Peers

Countries citing papers authored by Waheed Jamal

Since Specialization

Citations

This map shows the geographic impact of Waheed Jamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waheed Jamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waheed Jamal more than expected).

Fields of papers citing papers by Waheed Jamal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waheed Jamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waheed Jamal. The network helps show where Waheed Jamal may publish in the future.

Co-authors

The 25 scholars most cited alongside Waheed Jamal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Waheed Jamal Line = papers co-authored together Waheed Jamal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials The Lancet ·Faı̈ez Zannad, João Pedro Ferreira, Stuart Pocock, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal, Milton Packer Hit paper breakdown →	2020	831
2	Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction Circulation ·Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Peter E. Carson, Inder S. Anand, Wolfram Doehner, Markus Haass, Michel Komajda, Alan B. Miller, Steen Pehrson, John R. Teerlink, Martina Brueckmann, Waheed Jamal, Cordula Zeller, Sven Schnaidt, Faı̈ez Zannad Hit paper breakdown →	2020	266
3	Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Circulation ·Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, Nikolaus Marx, Carolyn S.P. Lam, Sven Schnaidt, Anne Pernille Ofstad, Martina Brueckmann, Waheed Jamal, E A Bocchi, Piotr Ponikowski, Sergio V. Perrone, James L. Januzzi, Subodh Verma, Michael Böhm, João Pedro Ferreira, Stuart Pocock, Faı̈ez Zannad, Milton Packer Hit paper breakdown →	2020	243
4	International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD) American Heart Journal ·Ajay K. Kakkar, Iris Mueller, Jean‐Pierre Bassand, David Fitzmaurice, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gregory Y.H. Lip, LG Mantovani, Freek W.A. Verheugt, Waheed Jamal, Frank Misselwitz, S. K. Rushton-Smith, Alexander G.G. Turpie	2011	171
5	Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial European Journal of Heart Failure ·Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Waheed Jamal, Afshin Salsali, Janet Schnee, Karen Kimura, Cordula Zeller, Jyothis T. George, Martina Brueckmann, Faı̈ez Zannad, Milton Packer	2019	169
6	Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure Journal of the American College of Cardiology ·João Pedro Ferreira, Faı̈ez Zannad, Stuart Pocock, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Waheed Jamal, Dominik Steubl, Elke Schueler, Milton Packer	2021	113
7	Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial European Heart Journal ·Javed Butler, Stefan D. Anker, Gerasimos Filippatos, Muhammad Shahzeb Khan, João Pedro Ferreira, Stuart Pocock, Nadia Giannetti, James L. Januzzi, Ileana L. Piña, Carolyn S.P. Lam, Piotr Ponikowski, Naveed Sattar, Subodh Verma, Martina Brueckmann, Waheed Jamal, Ola Vedin, Barbara Peil, Cordula Zeller, Faı̈ez Zannad, Milton Packer	2020	110
8	Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload Journal of the American College of Cardiology ·Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Naveed Sattar, Martina Brueckmann, Waheed Jamal, Daniel Cotton, Tomoko Iwata, Faı̈ez Zannad	2021	107
9	Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial European Heart Journal ·Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Hans‐Peter Brunner‐La Rocca, Stefan Janssens, Hiroyuki Tsutsui, Jian Zhang, Martina Brueckmann, Waheed Jamal, Daniel Cotton, Tomoko Iwata, Janet Schnee, Faı̈ez Zannad	2020	81
10	A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment Thrombosis and Haemostasis ·Sylvia Haas, Reinhold Kreutz, LG Mantovani, Cassandra Wolos Pattanayak, Gerlind Holberg, Waheed Jamal, André Schmidt, Martin van Eickels, Michael R. Lassen, Alexander G.G. Turpie	2013	71
11	Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure Journal of the American College of Cardiology ·Michael Böhm, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Felix Mahfoud, Martina Brueckmann, Waheed Jamal, Anne Pernille Ofstad, Elke Schüler, Piotr Ponikowski, Christoph Wanner, Faı̈ez Zannad, Milton Packer	2021	55
12	Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial The Lancet Diabetes & Endocrinology ·Darren K. McGuire, Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, David Fitchett, Stefan D. Anker, Stuart Pocock, Stefan Kaspers, Jyothis T. George, Maximilian von Eynatten, Odd Erik Johansen, Waheed Jamal, Michaela Mattheus, U Elsasser, Stefan Hantel, Søren S. Lund	2020	50
13	Rationale and Design of The Emperial-Preserved and Emperial-Reduced Trials of Empagliflozin in Patients with Chronic Heart Failure European Journal of Heart Failure ·William T. Abraham, Piotr Ponikowski, Martina Brueckmann, Cordula Zeller, Hemani Macesic, Barbara Peil, Michèle Brun, Anastasia Ustyugova, Waheed Jamal, Afshin Salsali, JoAnn Lindenfeld, Stefan D. Anker	2019	38
14	Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial European Journal of Heart Failure ·Milton Packer, James L. Januzzi, João Pedro Ferreira, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Martina Brueckmann, Waheed Jamal, Daniel Cotton, Tomoko Iwata, Faı̈ez Zannad	2021	28
15	Design of a Prospective Patient-Level Pooled Analysis of Two Parallel Trials of Empagliflozin in Patients with Established Heart Failure European Journal of Heart Failure ·Milton Packer, Javed Butler, Gerasimos Filippatos, Faı̈ez Zannad, João Pedro Ferreira, Cordula Zeller, Martina Brueckmann, Waheed Jamal, Stuart Pocock, Stefan D. Anker	2020	18
16	Application to Vascular Adventitia of a Nonviral Vector for TIMP-1 Gene Therapy to Prevent Intimal Hyperplasia Human Gene Therapy ·Qinghai Meng, Waheed Jamal, Stephen L. Hart, Jean R. McEwan	2006	1
17	131-LB: Empagliflozin Reduces the Total Burden of All-Cause Hospitalizations (ACH) and Mortality in EMPA-REG Outcome Diabetes ·Silvio E. Inzucchi, Bernard Zinman, Christoph Wanner, David Fitchett, Stefan D. Anker, STUART POCOCK, Stefan Kaspers, Jyothis T. George, Odd Erik Johansen, Waheed Jamal, Stefan Hantel, Søren S. Lund	2020	1
18	Assessing and enhancing pediatric residents’ knowledge and skills in tracheostomy care through simulation-based training Frontiers in Pediatrics ·Hasan Ghandourah, Nada Townsi, Meral Abualjdyel, Asad Khan, Narvanie Seebran, Salma Z Al- Mowalled, Waheed Jamal, Haifaa Kashqari, Saif Selati	2025	0
19	P6270Empagliflozin reduces the total burden of first and recurrent hospitalisations in patients with type 2 diabetes and established cardiovascular disease European Heart Journal ·Darren K. McGuire, Bernard Zinman, Silvio E. Inzucchi, Stefan D. Anker, Christoph Wanner, Stefan Kaspers, M. von Eynatten, Odd Erik Johansen, U Elsasser, Stuart Pocock, David Fitchett, Waheed Jamal, Stefan Hantel, Søren S. Lund	2019	0
20	Cardiovascular and Kidney Outcomes with Empagliflozin in Heart Failure Diabetologie und Stoffwechsel ·Faı̈ez Zannad, Javed Butler, G Filippatos, Stuart Pocock, Waheed Jamal, Janet Schnee, Cordula Zeller, Martina Brueckmann, SD Anker, Milton Packer	2021	0

About Waheed Jamal

Waheed Jamal is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine and Pharmacy, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (17 papers), Pancreatic function and diabetes (9 papers), Heart Failure Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (3 papers), Cardiovascular Function and Risk Factors (3 papers), Diabetes Management and Research (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Cardiology and Cardiovascular Medicine (1.4k citations), Internal Medicine (135 citations), Pulmonary and Respiratory Medicine (497 citations) and Nephrology (102 citations). Waheed Jamal has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Martina Brueckmann, Gerasimos Filippatos, Faı̈ez Zannad, Milton Packer, Javed Butler, Stefan D. Anker, Stuart Pocock, João Pedro Ferreira, Anne Pernille Ofstad and Egon Pfarr. Their work appears in journals such as European Journal of Heart Failure, European Heart Journal, Journal of the American College of Cardiology, Circulation and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact